CLINICAL TRIALS PROFILE FOR DURAMORPH PF
✉ Email this page to a colleague
All Clinical Trials for DURAMORPH PF
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00335517 ↗ | Safety and Efficacy of DepoDur in Lumbar Spine Surgery Patients | Completed | EKR Therapeutics, Inc | N/A | 2006-06-01 | The purpose of the study is to help determine the appropriate dose of DepoDur for use in spinal surgery. The study will also assess the safety of this drug in this patient population. |
| NCT00335517 ↗ | Safety and Efficacy of DepoDur in Lumbar Spine Surgery Patients | Completed | University of Rochester | N/A | 2006-06-01 | The purpose of the study is to help determine the appropriate dose of DepoDur for use in spinal surgery. The study will also assess the safety of this drug in this patient population. |
| NCT00385541 ↗ | Comparison of Side Effects of Morphine and Hydromorphone Patient-Controlled Analgesia (PCA) | Completed | Columbia University | Phase 4 | 2003-11-01 | Both morphine and hydromorphone are pain medications commonly used after surgery. It is thought at the institution that hydromorphone causes less side effects but this has not been studied. The study proposes to treat the patients with either morphine or hydromorphone and determine how much nausea, vomiting, and itching they have with each drug |
| NCT01298778 ↗ | High Pain Intervention in Cesarean Sections | Completed | Wake Forest School of Medicine | N/A | 2010-08-01 | In previous studies the investigators have seen that the severity of pain one day after cesarean delivery can predict the presence of pain and depression 2 months later. The investigators believe those at risk for severe acute post-partum pain can be identified, and medical interventions can be tailored to manage postoperative pain more effectively. |
| NCT01298778 ↗ | High Pain Intervention in Cesarean Sections | Completed | Wake Forest University Health Sciences | N/A | 2010-08-01 | In previous studies the investigators have seen that the severity of pain one day after cesarean delivery can predict the presence of pain and depression 2 months later. The investigators believe those at risk for severe acute post-partum pain can be identified, and medical interventions can be tailored to manage postoperative pain more effectively. |
| NCT01362998 ↗ | Epidural Morphine Versus Epidural Fentanyl Infusion Following Cesarean Section | Unknown status | Goodman, Evan, M.D. | N/A | 2011-03-01 | For post-Cesarean analgesia, the investigators will compare the efficacy of single-shot epidural preservative free morphine with a continuous epidural fentanyl infusion. The investigators will be comparing the patient's pain level and satisfaction with the two techniques, as well as the side effects that the patients experience, such as itching, nausea, back pain and respiratory depression. |
| NCT01593280 ↗ | TAP Catheters Versus Intrathecal Morphine for Cesarean Section | Unknown status | I-Flow | N/A | 2012-05-01 | Morphine, when given as part of spinal anesthesia, is associated high incidence of nausea and pruritus, which may affect quality of recovery. The investigators hypothesize that long-acting local anesthetic infusions via TAP catheter can provide better quality of recovery after cesarean section than spinal morphine. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DURAMORPH PF
Condition Name
Clinical Trial Locations for DURAMORPH PF
Trials by Country
Clinical Trial Progress for DURAMORPH PF
Clinical Trial Phase
Clinical Trial Sponsors for DURAMORPH PF
Sponsor Name
